107 related articles for article (PubMed ID: 8484185)
21. Progestogens with antimineralocorticoid activity.
Losert W; Casals-Stenzel J; Buse M
Arzneimittelforschung; 1985; 35(2):459-71. PubMed ID: 4039568
[TBL] [Abstract][Full Text] [Related]
22. Mineralocorticoid activity of 21-deoxyaldosterone derivatives: structure-function studies.
Wynne KN; Rae ID; O'Keefe DF; Adam WR; Pearce P; Stockigt JR; Funder JW
J Steroid Biochem; 1981 Oct; 14(10):1041-4. PubMed ID: 6272022
[No Abstract] [Full Text] [Related]
23. Relationships of the molecular structure of aldosterone derivatives with their binding affinity for mineralocorticoid receptor.
Yamakawa M; Ezumi K; Shiro M; Nakai H; Kamata S; Matsui T; Haga N
Mol Pharmacol; 1986 Dec; 30(6):585-9. PubMed ID: 3023811
[TBL] [Abstract][Full Text] [Related]
24. Aldosterone Glucuronide, an Important Biomarker: Synthesis and Structure Elucidation of Novel Isomers.
Guha S; Senthilkumar S; Voß E; Tietze LF
Chemistry; 2020 Dec; 26(67):15733-15737. PubMed ID: 33211377
[TBL] [Abstract][Full Text] [Related]
25. Mineralo- and glucocorticoid effects on renal excretion of electrolytes.
Campen TJ; Vaughn DA; Fanestil DD
Pflugers Arch; 1983 Oct; 399(2):93-101. PubMed ID: 6647008
[TBL] [Abstract][Full Text] [Related]
26. Ouabain causes kaliuresis and works synergistically with aldosterone in vivo.
Sekihara H; Yazaki Y
Life Sci; 1993; 53(12):975-80. PubMed ID: 8361328
[TBL] [Abstract][Full Text] [Related]
27. 19-Nor deoxycorticosterone (19-nor DOC): mineralocorticoid receptor affinity higher than aldosterone, electrolyte activity lower.
Funder JW; Mercer J; Ingram B; Feldman D; Wynne K; Adam WR
Endocrinology; 1978 Oct; 103(4):1514-7. PubMed ID: 744165
[TBL] [Abstract][Full Text] [Related]
28. Receptor binding and biological activity of 18-oxocortisol.
Gomez-Sanchez CE; Gomez-Sanchez EP; Smith JS; Ferris MW; Foecking MF
Endocrinology; 1985 Jan; 116(1):6-10. PubMed ID: 2856875
[TBL] [Abstract][Full Text] [Related]
29. Induction of flavokinase (EC 2.7.1.26) by aldosterone in the rat kidney.
Trachewsky D; Oakes ML; Morris DJ
Endocrinology; 1985 Mar; 116(3):879-88. PubMed ID: 2982577
[TBL] [Abstract][Full Text] [Related]
30. Structure-activity relationship of new steroidal aldosterone antagonists. Comparison of the affinity for mineralocorticoid receptors in vitro and the antialdosterone activity in vivo.
Wambach G; Casals-Stenzel J
Biochem Pharmacol; 1983 May; 32(9):1479-85. PubMed ID: 6222738
[TBL] [Abstract][Full Text] [Related]
31. 18-substituted steroids--Part 17. 2 alpha-hydroxylated liver metabolites of aldosterone identified by high-field [1H]NMR spectroscopy.
Latif SA; Morris DJ; Wei L; Kirk DN; Burke PJ; Toms HC; Shackleton CH
J Steroid Biochem; 1989 Dec; 33(6):1119-25. PubMed ID: 2615356
[TBL] [Abstract][Full Text] [Related]
32. The amygdala: site of genomic and nongenomic arousal of aldosterone-induced sodium intake.
Sakai RR; McEwen BS; Fluharty SJ; Ma LY
Kidney Int; 2000 Apr; 57(4):1337-45. PubMed ID: 10760064
[TBL] [Abstract][Full Text] [Related]
33. Aldosterone and growth hormone: influence of diet and hypophysectomy on rat renal response.
Simone PG; Solomon S
Proc Soc Exp Biol Med; 1970 Mar; 133(3):786-9. PubMed ID: 5435569
[No Abstract] [Full Text] [Related]
34. Effect of administered mineralocorticoids or ACTH in pregnant women. Attenuation of kaliuretic influence of mineralocorticoids during pregnancy.
Ehrlich EN; Lindheimer MD
J Clin Invest; 1972 Jun; 51(6):1301-9. PubMed ID: 4336938
[TBL] [Abstract][Full Text] [Related]
35. Renal receptor-binding activity of reduced metabolites of aldosterone: evidence for a mineralocorticoid effect outside of the classic aldosterone receptor system.
Gomez-Sanchez CE; Smith JS; Ferris MW; Gomez-Sanchez EP
Endocrinology; 1984 Aug; 115(2):712-5. PubMed ID: 6086276
[TBL] [Abstract][Full Text] [Related]
36. Synthetic approaches towards the multi target drug spironolactone and its potent analogues/derivatives.
Larik FA; Saeed A; Shahzad D; Faisal M; El-Seedi H; Mehfooz H; Channar PA
Steroids; 2017 Feb; 118():76-92. PubMed ID: 28041953
[TBL] [Abstract][Full Text] [Related]
37. Orally active mineralocorticoid agonists and antagonists: delta 1-derivatives of aldosterone and 18-deoxyaldosterone.
Adam WR; Funder JW; Ulick S
Endocrinology; 1981 Feb; 108(2):517-21. PubMed ID: 6256153
[TBL] [Abstract][Full Text] [Related]
38. Interaction of synthetic progestagens with renal mineralocorticoid receptors.
Wambach G; Higgins JR; Kem DC; Kaufmann W
Acta Endocrinol (Copenh); 1979 Nov; 92(3):560-7. PubMed ID: 574701
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the mineralocorticoid activity of 18-hydroxycorticosterone.
Huston G; Martin VI; Al-Dujaili EA; Edwards CR
Clin Sci (Lond); 1981 Aug; 61(2):201-6. PubMed ID: 7261543
[TBL] [Abstract][Full Text] [Related]
40. Effects of triiodothyronine and aldosterone on water and electrolyte excretion by the hypophysectomized rat.
Bauman JW; Earls C
Endocrinology; 1967 Jun; 80(6):1185-8. PubMed ID: 6027221
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
